Clinical Trials · NCT01847313
The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Karl Neff
- Enrollment
- 20
- Start date
- Apr 2013
- Locations
- 1 site, Ireland
- Primary endpoint
- MCP-1:Creatinine Ratio in Urine